Glycation and microglial reaction in lesions of Alzheimer's disease

Neurobiology of Aging

Volumn 17, Issue 5, 1996, Pages 733-743

  Dickson, Dennis W ^a   Sinicropi, Stefano ^b   Yen, Shu Hui ^b   Ko, Li Wen ^b   Mattiace, Linda A ^b   Bucala, Richard ^b   Vlassara, Helen ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

AB; AGE; Apolipoprotein E; Glycation; Immunocytochemistry; Immunofluorescence; Microglia; Neurofibrillary tangles; PHF ; Senile plaques

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

AGED; ALZHEIMER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLYCATION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MALE; MICROGLIA; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; REVIEW;

EID: 0030250714     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-4580(96)00116-9     Document Type: Article

References (64)

1. 1. Abraham, C. R.; Selkoe, D. J.; Potter, H. Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52:487-501: 1988.
2. 2. Brownlee, M.; Cerami, A.; Vlassara, H. Advanced glycation end-products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318:1315-1321; 1988.
3. 3. Bucala, R.; Mitchell, R.; Arnold, K.; Innerarity, T.; Vlassara, H.; Cerami, A. Identification of the major site of apolipoprotein B modification by advanced glycosylation end products blocking uptake by the low density lipoprotein receptor. J. Biol. Chem. 270:10828-10832, 1995.
4. 4. Bugiani, O.; Tagliavini, F.; Giaccone, G. Preamyloid deposits, amyloid deposits, and senile plaques in Alzheimer's disease, Down syndrome, and aging. Ann. NY Acad. Sci. 640:122-128; 1991.
5. 5. Colaco, C. A. L. S.; Roser, B. J. Atherosclerosis and glycation. Bioessays 16:145-147; 1994.
6. 6. Crystal, H. A.; Dickson, D. W.; Sliwinski, M.; Lipton, R. B.; Blau, A.; Masur, D. Associations of status and change measures of neuropsychological function with pathology in elderly, originally nondemented subjects. Arch. Neurol. 53:82-87; 1996.
7. 7. Davies, L.; Molska, B.; Hilbich, C.; Multhaup, G.; Martins, R.; Simms, G.; Beyreuther, K.; Masters, C. L. A4 amyloid deposition and the diagnosis of Alzheimer's disease: Prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurology 38:1688-1693; 1988.
8. 8. Delacre, P.; Duyckaerts, C.; Masters, C.; Beyreuther, K.; Piette, F.; Hauw, J.-J. Large amounts of neocortical β/A4 deposits without neuritic plaques nor tangles in a psychometrically assessed, nondemented person. Neurosci. Lett. 116:87-93: 1990.
9. 9. Dickson, D. W.; Crystal, H.; Mattiace, L. A., Kress, Y.; Schwagerl, A.; Davies, P.; Yen, S.-H. Diffuse Lewy body disease: Light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol. (Berl.) 78:572-584; 1989.
10. 10. Dickson, D. W.; Crystal, H. A.; Mattiace, L. A.; Masur, D. M.; Blau, A.; Davies, P.; Yen, S.-H.; Aronson, M. K. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol. Aging 13:1-11: 1992.
11. 11. Dickson, D. W.; Farlo, J.; Davies, P.; Crystal, H.; Fuld, P.; Yen, S.-H. Alzheimer's disease: A double-labeling immunohistochemical study of senile plaques. Am. J. Pathol. 132:86-101; 1988.
12. 12. Dickson, D.W.; Ivanushkin, A.; Heitner, J.; Yen, S.-H.; Davies, P. Apolipoprotein-E immunoreactivity is increased in deposits of Alzheimer's disease, but not pathological aging or diffuse Lewy body disease. In: Iqbal, H.; Mortimer, J. A.; Winblad, B.; Wisniewski, H. M., eds. Research advances in Alzheimer's disease and related disorders. New York: John Wiley & Sons; 1995:371-383.
13. 13. Dickson, D. W.; Ksiezak-Reding, H.; Liu, W.-K.; Davies, P.; Crowe, A.; Yen, S.-H. Immunocytochemistry of neurotibrillary tangles (NFT) with antibodies to subregions of tau protein: Identification of hidden and cleaved epitopes and a new phosphorylation site. Acta Neuropathol. (Berl.) 84:596-605; 1992.
14. 14. Dickson, D.W.; Lee, S. C. Microglia. In: Davis. R. L.; Robertson, D. M., eds. Textbook of neuropathology, 3rd ed. Baltimore: Williams & Wilkins; 1996.
15. 15. Dickson, D. W.; Liu, W.-K.; Kress. Y.; Ku, J.; DeJesus, O.; Yen, S.-H. Phosphorylated tau immunoreactivity of granulovacuolar bodies (GVB) of Alzheimer's disease: Localization of two amino terminal tau epitopes in GVB. Acta Neuropathol. (Berl.) 85:463-470; 1993.
16. 16. Dickson, D. W.; Mattiace, L. A. Astrocytes and microglia in human brain share an epitope recognized by a B-lymphocyte-specific monoclonal antibody (LN-1). Am. J. Pathol. 135:135-142; 1989.
17. 17. Diedrich, J. F.; Minnigan, H.; Carp, R. I.; Whitaker, J. N.; Race, R.; Frey, W. II; Haase, A. T. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J. Virol. 65:4759-4768: 1991.
18. 18. Eikelenboora, P.; Rozemuller, J. M.; Kraal, G.; Stam, F. C.; McBride, P. A.; Bruce, M. E.; Fraser, H. Cerebral amyloid plaques in Alzheimer's disease but not in scrapie-affected mice are closely associated with a local inflammatory process. Virch Arch. B Cell Pathol. Mol. Pathol. 60:329-336; 1991.
19. 19. Frederickson, R. C. Astroglia in Alzheimer's disease. Neurobiol. Aging 13:239-253; 1992.
20. 20. Gowing, E.; Roher, A. E.; Woods, A. S.; Cotter, R. J.; Chaney, M.; Little, S. P.; Ball, M. J. Chemical characterization of the Aβ17-42 peptide, a component of diffuse amyloid deposits of Alzheimer's disease. J. Biol. Chem. 269:10987-10990; 1994.
21. 21. Haas, C.; Schlossmacher, M. G.; Hung, A. Y.; Vigo-Pelfrey, C.; Mellon, A.; Ostaszewski, B. L.; Lieberburg, I.; Koo, E. H.; Schenk, D.; Teplow, D, B,; Selkoe, D. J. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359:322-325; 1992.
22. 22. Itagaki, S.; McGeer, P. L.; Akiyama, H.; Zhu, S.; Selkoe, D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 24:173-182; 1989.
23. 23. Iwatsubo, T.; Odaka, A.; Suzuki, N.; Mizusawa, H.; Nukina, N.; Ihara, Y. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific A monoclonals: Evidence that an initially deposited species is Aβ42(43). Neuron 13:45-53; 1994.
24. 24. Katzman, R.; Terry. R. D.; DeTeresa, R.; Brown, T.; Davies, P.; Fuld, P.; Reinbing, X.; Peck. A. Clinical, pathologic and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 23:138-144; 1988.
25. 25. Ledesma, M.; Bonay, P.; Colaco, C.; Avila, J. Analysis of microtubule-associated protein tau glycation in paired helical filaments. J. Biol. Chem. 269:21614-21619; 1994.
26. 26. Lee, S. C.; Liu, W.; Dickson, D. W.; Brosnan, C. F.; Berman, J. W. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J. Immunol. 150: 2659-2667; 1993.
27. 27. Lee, S. C.; Liu, W.; Roth, P.; Dickson, D. W.; Berman, J. W.; Brosnan, C. F. Macrophage colony stimulating factor (CSF-1) in human fetal astrocytes and microglia: Differential regulation by cytokines and LPS, and modulation of class II MHC on microglia. J. Immunol. 150:594-604; 1993.
28. 28. Liu, W.-K.; Williams, R. T.; Hall, F. L.; Dickson, D. W.; Yen, S.-H. Detection of a cdc2-related kinase associated with Alzheimer paired helical filaments. Am. J. Pathol. 146:228-238; 1995.
29. 29. Mahley. R. W. Apolipoprotein E: Cholestrol transport protein with expanding role in cell biology. Science 240:622-630; 1988.
30. 30. Makita, Z.; Vlassara, H.; Cerami, A.; Bucala, R. Immunochemical detection of advanced glycation end products in vivo. J. Biol. Chem. 267:5133-5138; 1992.
31. 31. Malik, N. S.; Meek, K. M. The inhibition of sugar-induced structural alterations in collagen by aspirin and other compounds. Biochem. Biophys. Res. Commun. 199:683-636; 1994.
32. 32. Mattiace, L. A.; Davies, P.; Dickson, D. W. Detection of HLA-DR in human microglia is dependent on clinical and technical factors. Am. J. Pathol. 136:1101-1114; 1990.
33. 33. McGeer, P. L.; Itagaki, S.; Tago, H.; McGeer, E. G. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci. Lett. 79: 195-200; 1987.
34. 34. McGeer, P. L.; Kawamata, T. Walker, D. G. Distribution of clusterin in Alzheimer brain tissue. Brain Res. 579:337-341; 1992.
35. 35. Miyata, T.; Inagi, R.; Iida, Y.; Sato, M.; Yamada, N.; Oda, O.; Maeda, K.; Seo, H. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1. J. Clin. Invest. 93:521-528; 1994.
36. 36. Miyata, T.; Inagi, R.; Wada, Y.; Ueda, Y.; Iida, Y.; Takahashi, M.; Taniguchi. N.; Maeda, K. Glycation of human beta 2-microglobulin in patients with hemodialysis-associated amyloidosis: Identification of the glycated sites. Biochemistry 33:12215-12221; 1994.
37. 37. Miyata, T.; Oda, O.; Inagi, R.; Iida, Y.; Araki, N.; Yamada, N.; Horiuchi, S.; Taniguchi, N.; Maeda, K.; Kinoshita, T. beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J. Clin. Invest. 92:1243-1252; 1993.
38. 38. Nakamura, Y.; Horii, Y.; Nishino, T.; Shiiki, H.; Sakaguchi, Y.; Kagoshima, T.; Dohi, Y.; Makita, Z.; Vlassara, H.; Bucala, R. Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. Am. J. Pathol. 143:1649-1656; 1993.
39. 39. Namba, Y.; Tomonaga, M.; Kawasaki. H.; Otomo, E.; Ikeda, K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and NFT in Alzheimer's disease & kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541:163-166; 1991.
40. 40. Neeper, M.; Schmidt, A. M.; Brett, J.; Yan, S. D.; Wang. F.; Pan, Y.-C. E.; Elliston, K.; Stern, D.; Shaw, A. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267:14998-15004; 1992.
41. 41. Ohgami, T.; Kitamoto, T.; Shin, R. W.; Kaneko, Y.; Ogomori, K.; Tateishi, J, Increased senile plaques without microglia in Alzheimer s disease. Acta Neuropathol. (Berl.) 81:242-247; 1991.
42. 42. Roher, A. E.; Lowenson, J. D.; Clarke, S.; Wolkow, C.; Wang, R.; Cotter, R. J.; Reardon, I. M.; Zurcher-Neely, H. A.; Heinriksonm, R. L.; Ball, M. J.; Greenberg, B. D. Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease, J. Biol. Chem. 268:3072-3083; 1993.
43. 43. Roher, A. E.; Lowenson, J. D.; Clarke, S.; Woods, A. S.; Cotter, R. J.; Cowing, E.; Ball, M. J. β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: Implications for the pathology of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90:10836-10840; 1993.
44. 44. Rozemuller, J. M.; Eikelenboom, P.; Stam, F. C.; Beyreuther, K.; Masters, C. L. A4 protein in Alzheimer's disease: Primary and secondary cellular events in extracellular amyloid deposition. J. Neuropathol. Exp. Neurol, 48:674-691; 1989.
45. 45. Sasaki, A.; Nakazato, Y. The identity of cells expressing MHC class II antigens in normal and pathologic human brain. Neuropathol, Appl. Neurobiol. 18:13-26; 1992.
46. 46. Selkoe, D. J. Alzheimer's disease: a central role for amyloid. J. Neuropathol. Exp. Neurol. 53:438-447; 1994.
47. 47. Seubert, P.; Vigo-Pelfrey, C.; Esch, F.; Lee, M.; Dovey. H.; Davis. D.; Sinha, S.; Schlossmacher, M.; Whaley, J.; Swindlehurst, C.; McCormack, R.; Wolfert, R.; Selkoe, D. J.; Lieberburg, I.; Schenk, D. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 359:325-327; 1992.
48. 48. Smith, M. A.; Taneda, S.; Richey, P. L.; Miyata, S.; Yan, S.-D.; Stern, D.; Sayre, L. M.; Monnier, V. M.; Perry, G. Advanced Maillard reaction products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. USA 91:5710-5714; 1994.
49. 49. Snow, A. D.; Willmer, J,; Kisilevsky, R. Sulfated glycosaminoglycans: A common constituent of all amyloids? Lab. Invest. 56:120-123; 1987.
50. 50. Strittmatter, W. J.; Weisgraber, K. H.; Goedert, M.; Saunders, A. M.; Huang, D.; Corder. E. H.; Dong, L. M.; Jakes, R.; Alberts, M. J.; Gilbert, J. R.; Han, S.-H.; Hulette, C.; Einstein, G.; Schmechel, D.E.; Pericak-Vance, M. A.; Roses, A. D. Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp. Neurol. 125:163-171; 1994.
51. 51. Vitek, M. P.; Bhattacharya, K.; Glenening, J. M.; Stopa, E.; Vlassara, H.; Bucala, R; Manogue, K.; Cerami, A. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc. Nad. Acad. Sci. USA 91:4766-4770; 1994.
52. 52. Vlassara, H.; Moldawaer, L.; Chan, B. Macrophage/monocyte receptor for nonenzymatically glycosylated proteins is upregulated by cachectin/tumor necrosis factor. J. Clin. Invest. 84:1813-1820; 1989.
53. 53. Vlassara, H.; Brownlee, M.; Manogue, K. R.; Dinarello, C.; Pasagian. A. Cachectin/TNF and IL-1 induced by glucose modified proteins: Role in normal tissue remodeling. Science 240:1546-1548; 1988.
54. 54. Vlassara, H.; Bucala, R.; Striker, L. Pathogenic effects of advanced glycosylation: Biochemical, biologic, and clinical implications for diabetes and aging. Lab. Invest. 70:138-151; 1994.
55. 55. Wisniewski, H. M.; Vorbrodt, A. W.; Wegiel, J.; Morys, J.; Lossinsky, A. S. Ultrastructure of the cells forming amyloid fibers in Alzheimer disease and scrapie. Am. J. Med. Genet. Suppl. 7:287-297; 1990.
56. 56. Wisniewski, T.; Castano, E. M.; Golabek, A.; Vogel. T.; Frangione, B. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol. 145:1030-1035; 1994.
57. 57. Wisniewski, T.; Lalowski, M.; Golabek, A.; Vogel, T.; Frangione, B. Is Alzheimer's disease an apolipoprotein E amyloidosis? Lancet 345: 956-958; 1995.
58. 58. Wolozin, B. L.; Pruchnicki, A.; Dickson, D. W.; Davies, P. A neuronal antigen in the brains of patients with Alzheimer's disease. Science 232:648-650; 1986.
59. 59. Yan, S.-D.; Chen, X.; Schmid. A.-M; Brett, J.; Godman, G.; Zou, Y.-S.; Scott, C. W.; Caputo, C; Frappier, T.; Smith, M. A.; Perry, G.; Yen, S.-H.; Stern, D. Glycated tau protein in Alzheimer disease: A mechanism for induction of oxidant stress. Proc. Natl. Acad. Sci. USA 91:7787-7790; 1994.
60. 60. Yan, S.-D.; Schmid, A.-M.; Anderson, G.M.; Zhang, J.; Brett, J.; Zou, Y.-S.; Pinsky, D.; Stern, D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol, Chem. 269:9889-9892; 1994.
61. 61. Yen, S.-H.; Crowe, A.; Dickson, D.W. Monoclonal antibodies to Alzheimer neurofibrillary tangles. 1. Identification of polypeptides. Am. J. Pathol. 120:282-291; 1985.
62. 62. Yen, S.-H.; Liu, W.-K.; Hall, F.L.; Yan, S.-D.; Stern, D.; Dickson, D. W. Alzheimer neurofibrillary lesions: Molecular nature and poten-tial roles of different components. Neurobiol. Aging 16:381-387; 1995.
63. 63. Younkin, S. G. Processing of the Alzheimer's disease beta A4 amyloid protein precursor (APP). Brain Pathol. 1:253-262; 1991.
64. 64. Yui, S.; Sasaki, T.; Araki, N.; Horiuchi, S,; Yamazaki, M. Induction of macrophage growth by advanced glycation end products of the Maillard reaction. J. Immunol. 152:1943-1949; 1994.